19-53906395-C-T
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP2BS2_Supporting
The NM_002739.5(PRKCG):c.1843C>T(p.Arg615Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000134 in 1,566,810 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
PRKCG
NM_002739.5 missense
NM_002739.5 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 0.387
Publications
1 publications found
Genes affected
PRKCG (HGNC:9402): (protein kinase C gamma) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PRKCG Gene-Disease associations (from GenCC):
- spinocerebellar ataxia type 14Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PP2
Missense variant in the PRKCG gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 36 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Gene score misZ: 3.0601 (below the threshold of 3.09). Trascript score misZ: 3.8304 (above the threshold of 3.09). GenCC associations: The gene is linked to spinocerebellar ataxia type 14.
BS2
High AC in GnomAd4 at 6 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRKCG | NM_002739.5 | c.1843C>T | p.Arg615Cys | missense_variant | Exon 17 of 18 | ENST00000263431.4 | NP_002730.1 | |
| PRKCG | NM_001316329.2 | c.1843C>T | p.Arg615Cys | missense_variant | Exon 17 of 19 | NP_001303258.1 | ||
| PRKCG | XM_047439092.1 | c.1459C>T | p.Arg487Cys | missense_variant | Exon 18 of 20 | XP_047295048.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PRKCG | ENST00000263431.4 | c.1843C>T | p.Arg615Cys | missense_variant | Exon 17 of 18 | 1 | NM_002739.5 | ENSP00000263431.3 | ||
| PRKCG | ENST00000682028.1 | c.1843C>T | p.Arg615Cys | missense_variant | Exon 17 of 19 | ENSP00000507230.1 | ||||
| PRKCG | ENST00000683513.1 | c.1735C>T | p.Arg579Cys | missense_variant | Exon 16 of 17 | ENSP00000506809.1 | ||||
| PRKCG | ENST00000682676.1 | n.1244C>T | non_coding_transcript_exon_variant | Exon 9 of 10 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151972Hom.: 0 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
151972
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000223 AC: 4AN: 179026 AF XY: 0.0000314 show subpopulations
GnomAD2 exomes
AF:
AC:
4
AN:
179026
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000106 AC: 15AN: 1414838Hom.: 0 Cov.: 31 AF XY: 0.0000143 AC XY: 10AN XY: 699480 show subpopulations
GnomAD4 exome
AF:
AC:
15
AN:
1414838
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
699480
show subpopulations
African (AFR)
AF:
AC:
2
AN:
32312
American (AMR)
AF:
AC:
2
AN:
38182
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25274
East Asian (EAS)
AF:
AC:
0
AN:
37142
South Asian (SAS)
AF:
AC:
4
AN:
80656
European-Finnish (FIN)
AF:
AC:
0
AN:
50144
Middle Eastern (MID)
AF:
AC:
1
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1086888
Other (OTH)
AF:
AC:
3
AN:
58528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151972Hom.: 0 Cov.: 29 AF XY: 0.0000269 AC XY: 2AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
6
AN:
151972
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41372
American (AMR)
AF:
AC:
0
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5152
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67990
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Sep 26, 2016
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
DANN
Pathogenic
DEOGEN2
Pathogenic
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
H
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.